AffyImmune Therapeutics
Dr. Cassian Yee is a Professor in the Department of Melanoma Medical Oncology and Department of Immunology at UT MD Anderson Cancer Center and Director of the Solid Tumor Cell Therapy Program. Dr. Yee is a pioneer in adoptive cell transfer (ACT) immunotherapy, which involves taking anti-cancer T cells from patients and then enhancing their anti-tumor capabilities before putting them back into patients. In addition to being a member of Cancer Research Institute’s Scientific Advisory Council, Dr. Yee is a leader of the CRI-SU2C Dream Team, serves on the Postdoctoral Fellowship Review Committee, and is a member of CRI’s global clinical investigator network.
This person is not in the org chart
This person is not in any offices
AffyImmune Therapeutics
AffyImmune Therapeutics is a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers.